Candriam Equities L Biotech.V USD Acc/ LU0317020203 /
NAV2024-03-27 | Chg.+26.7100 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
2,079.8999USD | +1.30% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2016 | - | - | - | 3.61 | 5.39 | -8.19 | 12.61 | -2.42 | 3.86 | -12.36 | 8.75 | -2.82 | - |
2017 | 5.51 | 6.90 | -0.08 | 1.23 | -3.06 | 9.25 | 2.56 | 6.40 | 0.81 | -6.34 | 0.29 | 1.54 | +26.78% |
2018 | 6.88 | -4.67 | -1.88 | -3.09 | 4.69 | 0.99 | 4.63 | 4.22 | -2.00 | -13.93 | 4.22 | -8.45 | -10.11% |
2019 | 13.27 | 3.46 | -0.54 | -4.84 | -4.71 | 9.42 | -2.29 | -2.34 | -4.19 | 10.53 | 11.85 | 2.47 | +33.93% |
2020 | -5.17 | -1.12 | -4.99 | 12.89 | 9.37 | 1.42 | -2.84 | 0.94 | 0.78 | -2.79 | 9.82 | 3.08 | +21.34% |
2021 | 1.90 | -2.51 | -4.18 | 2.81 | -2.18 | 6.45 | -1.37 | 4.00 | -4.15 | 0.25 | -4.29 | 2.37 | -1.59% |
2022 | -10.77 | -1.96 | 5.73 | -7.54 | -3.35 | 3.08 | 4.65 | 1.14 | -1.90 | 7.00 | 6.18 | -2.79 | -2.30% |
2023 | 3.02 | -5.67 | 0.45 | 2.29 | -1.19 | 1.26 | -0.13 | -0.15 | -4.28 | -6.10 | 5.99 | 13.49 | +7.70% |
2024 | 1.35 | 1.37 | 0.38 | - | - | - | - | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 15.72% | 18.75% | 16.07% | 20.19% | 22.86% |
Sharpe ratio | 0.65 | 1.66 | 0.76 | 0.03 | 0.22 |
Best month | +13.49% | +13.49% | +13.49% | +13.49% | +13.49% |
Worst month | +0.38% | -6.10% | -6.10% | -10.77% | -10.77% |
Maximum loss | -5.03% | -8.66% | -15.04% | -29.34% | -30.61% |
Outperformance | -1.00% | - | -1.80% | +3.49% | - |
All quotes in USD
Tranches
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Candriam Equities L Biotech.V US... | reinvestment | 2,079.8999 | +16.10% | +14.33% | |
Candriam Equities L Biotech.C EU... | reinvestment | 223.2200 | +15.38% | - | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,088.9299 | +13.38% | +6.42% | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,242.2400 | +15.59% | +23.90% | |
Candriam Equities L Biotech.I GB... | reinvestment | 3,455.9900 | +12.71% | +22.95% | |
Candriam Equities L Biotech.R GB... | reinvestment | 363.6200 | +13.59% | +27.14% | |
Candriam Equities L Biotech.R EU... | reinvestment | 328.9000 | +16.46% | +26.76% | |
Candriam Equities L Biotech.R CH... | reinvestment | 204.8800 | +11.72% | +5.39% | |
Candriam Equities L Biotech.V2 U... | reinvestment | 1,865.6000 | +17.18% | +17.47% | |
Candriam Equities L Biotech.N-H ... | reinvestment | 151.9100 | - | - | |
Candriam Equities L Biotech.V US... | reinvestment | 607.9500 | +15.44% | +12.33% | |
Candriam Equities L Biotech.I US... | reinvestment | 5,691.0000 | +15.96% | +13.91% | |
Candriam Equities L Biotech.C EU... | reinvestment | 200.5700 | +14.03% | +6.23% | |
Candriam Equities L Biotech.R US... | reinvestment | 270.5100 | +16.88% | +16.59% | |
Candriam Equities L Biotech.R EU... | reinvestment | 208.8800 | +14.35% | +8.84% | |
Candriam Equities L Biotech.C US... | reinvestment | 852.9000 | +15.86% | +13.77% | |
Candriam Equities L Biotech.C US... | paying dividend | 783.5000 | +15.82% | +13.66% |
Performance
YTD | +3.12% | ||
---|---|---|---|
6 Months | +16.05% | ||
1 Year | +16.10% | ||
3 Years | +14.33% | ||
5 Years | +52.84% | ||
Since start | +107.99% | ||
Year | |||
2023 | +7.70% | ||
2022 | -2.30% | ||
2021 | -1.59% | ||
2020 | +21.34% | ||
2019 | +33.93% | ||
2018 | -10.11% | ||
2017 | +26.78% |